SA

Songzhu An

CU Curegenix: 8 patents #1 of 7Top 15%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
University of California: 1 patents #8,022 of 18,278Top 45%
📍 Tangxia, CA: #22 of 74 inventorsTop 30%
Overall (All Time): #413,894 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
10660889 Compounds for treatment of cancer 2020-05-26
10285988 Compounds for treatment of fibrosis diseases 2019-05-14
10287550 Serum-free chemically defined cell culture medium Yanan Zhu 2019-05-14
10238652 Compounds for treatment of cancer 2019-03-26
10087181 Compound as WNT signaling inhibitor, composition, and use thereof 2018-10-02
9744169 Compounds for treatment of fibrosis diseases 2017-08-29
9713612 Compounds for treatment of cancer 2017-07-25
9556144 Compound as WNT signaling inhibitor, composition, and use thereof 2017-01-31
8785442 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof Chufang Li, Guisheng Zhou, Chen-Ming Huang 2014-07-22
7189524 Receptor ligands and methods of modulating receptors Jin-Long Chen, Hui Tian, Wendy Wen Zhong 2007-03-13
6919176 Polypeptides and nucleic acids associated with cancer Jianxin Yang 2005-07-19
6812335 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same Edward J. Goetzl 2004-11-02